Skip to content

Berberis Aristata and Metformin in Diabetic Patients

Synergistic Effect of Berberis Aristata and Metformin in Diabetic Patients-A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230202057310N3
Enrollment
295
Registered
2023-09-07
Start date
2023-09-10
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: Group A will be treated with Berberis aristata (550 mg twice a day) orally. The treatment regimen will be 6 weeks. Blood glucose, blood pressure, blood cholesterol

Sponsors

Muhammad Institute of Medical and Allied Sciences, Multan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age group of 25-70 years Both Genders (Male, Female) Married and unmarried Educated and uneducated Diabetic patients

Exclusion criteria

Exclusion criteria: Any type of mental disability Lactating females Having any type of physical disability History of chest pain bronchitis Any type of major surgery Pregnant females Asthma Angina MI Chronic illness related to cardiorespiratory ailments

Design outcomes

Primary

MeasureTime frame
Glucose level in diabetic patients. Timepoint: 6 weeks. Method of measurement: Blood glucose level by glucometer.;Cholesterol level. Timepoint: 6 weeks. Method of measurement: Lipid profile meter.;HbA1C. Timepoint: 6 weeks. Method of measurement: Blood sampling.

Secondary

MeasureTime frame
Cardiorespiratory parameters. Timepoint: 6 weeks. Method of measurement: Pulse oximeter, Manometer for blood pressure monitoring.

Countries

Pakistan

Contacts

Public ContactMaliha Khalid Khan

Muhammad Institute of Medical and Allied Sciences, Multan

malihatareen1997@gmail.com+92 312 6827130

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026